Global Antispasmodics Drugs Market Growth (Status and Outlook) 2025-2031

September 2025 | 117 pages | ID: G0E260B9F79CEN
LP Information

Abstracts

According to this study, the global Antispasmodics Drugs market size will reach US$ million by 2031.

One type of antispasmodic is used for smooth muscle contraction, especially in the tubular organs of the gastrointestinal tract. The effect is to prevent cramps in the stomach, intestines or bladder.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LPI (LP Information)' newest research report, the “Antispasmodics Drugs Industry Forecast” looks at past sales and reviews total world Antispasmodics Drugs sales in 2024, providing a comprehensive analysis by region and market sector of projected Antispasmodics Drugs sales for 2025 through 2031. With Antispasmodics Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Antispasmodics Drugs industry.

This Insight Report provides a comprehensive analysis of the global Antispasmodics Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Antispasmodics Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Antispasmodics Drugs market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Antispasmodics Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Antispasmodics Drugs.

This report presents a comprehensive overview, market shares, and growth opportunities of Antispasmodics Drugs market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Oral
• Injectable
• Others

Segmentation by Application:

• Hospital
• Special Clinic
• Home Care
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Allergan
• Hikma Pharmaceuticals
• Lannett
• Mylan
• Nexus Pharmaceuticals
• Akorn
• Aurobindo Pharma
• Daiichi Sankyo
• Fresenius Kabi
• Shanghai Fosun Pharmaceutical
• SunGen Pharma

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Antispasmodics Drugs Market Size (2020-2031)
  2.1.2 Antispasmodics Drugs Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Antispasmodics Drugs by Country/Region (2020, 2024 & 2031)
2.2 Antispasmodics Drugs Segment by Type
  2.2.1 Oral
  2.2.2 Injectable
  2.2.3 Others
2.3 Antispasmodics Drugs Market Size by Type
  2.3.1 Antispasmodics Drugs Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Antispasmodics Drugs Market Size Market Share by Type (2020-2025)
2.4 Antispasmodics Drugs Segment by Application
  2.4.1 Hospital
  2.4.2 Special Clinic
  2.4.3 Home Care
  2.4.4 Others
2.5 Antispasmodics Drugs Market Size by Application
  2.5.1 Antispasmodics Drugs Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Antispasmodics Drugs Market Size Market Share by Application (2020-2025)

3 ANTISPASMODICS DRUGS MARKET SIZE BY PLAYER

3.1 Antispasmodics Drugs Market Size Market Share by Player
  3.1.1 Global Antispasmodics Drugs Revenue by Player (2020-2025)
  3.1.2 Global Antispasmodics Drugs Revenue Market Share by Player (2020-2025)
3.2 Global Antispasmodics Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 ANTISPASMODICS DRUGS BY REGION

4.1 Antispasmodics Drugs Market Size by Region (2020-2025)
4.2 Global Antispasmodics Drugs Annual Revenue by Country/Region (2020-2025)
4.3 Americas Antispasmodics Drugs Market Size Growth (2020-2025)
4.4 APAC Antispasmodics Drugs Market Size Growth (2020-2025)
4.5 Europe Antispasmodics Drugs Market Size Growth (2020-2025)
4.6 Middle East & Africa Antispasmodics Drugs Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Antispasmodics Drugs Market Size by Country (2020-2025)
5.2 Americas Antispasmodics Drugs Market Size by Type (2020-2025)
5.3 Americas Antispasmodics Drugs Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Antispasmodics Drugs Market Size by Region (2020-2025)
6.2 APAC Antispasmodics Drugs Market Size by Type (2020-2025)
6.3 APAC Antispasmodics Drugs Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Antispasmodics Drugs Market Size by Country (2020-2025)
7.2 Europe Antispasmodics Drugs Market Size by Type (2020-2025)
7.3 Europe Antispasmodics Drugs Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Antispasmodics Drugs by Region (2020-2025)
8.2 Middle East & Africa Antispasmodics Drugs Market Size by Type (2020-2025)
8.3 Middle East & Africa Antispasmodics Drugs Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL ANTISPASMODICS DRUGS MARKET FORECAST

10.1 Global Antispasmodics Drugs Forecast by Region (2026-2031)
  10.1.1 Global Antispasmodics Drugs Forecast by Region (2026-2031)
  10.1.2 Americas Antispasmodics Drugs Forecast
  10.1.3 APAC Antispasmodics Drugs Forecast
  10.1.4 Europe Antispasmodics Drugs Forecast
  10.1.5 Middle East & Africa Antispasmodics Drugs Forecast
10.2 Americas Antispasmodics Drugs Forecast by Country (2026-2031)
  10.2.1 United States Market Antispasmodics Drugs Forecast
  10.2.2 Canada Market Antispasmodics Drugs Forecast
  10.2.3 Mexico Market Antispasmodics Drugs Forecast
  10.2.4 Brazil Market Antispasmodics Drugs Forecast
10.3 APAC Antispasmodics Drugs Forecast by Region (2026-2031)
  10.3.1 China Antispasmodics Drugs Market Forecast
  10.3.2 Japan Market Antispasmodics Drugs Forecast
  10.3.3 Korea Market Antispasmodics Drugs Forecast
  10.3.4 Southeast Asia Market Antispasmodics Drugs Forecast
  10.3.5 India Market Antispasmodics Drugs Forecast
  10.3.6 Australia Market Antispasmodics Drugs Forecast
10.4 Europe Antispasmodics Drugs Forecast by Country (2026-2031)
  10.4.1 Germany Market Antispasmodics Drugs Forecast
  10.4.2 France Market Antispasmodics Drugs Forecast
  10.4.3 UK Market Antispasmodics Drugs Forecast
  10.4.4 Italy Market Antispasmodics Drugs Forecast
  10.4.5 Russia Market Antispasmodics Drugs Forecast
10.5 Middle East & Africa Antispasmodics Drugs Forecast by Region (2026-2031)
  10.5.1 Egypt Market Antispasmodics Drugs Forecast
  10.5.2 South Africa Market Antispasmodics Drugs Forecast
  10.5.3 Israel Market Antispasmodics Drugs Forecast
  10.5.4 Turkey Market Antispasmodics Drugs Forecast
10.6 Global Antispasmodics Drugs Forecast by Type (2026-2031)
10.7 Global Antispasmodics Drugs Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Antispasmodics Drugs Forecast

11 KEY PLAYERS ANALYSIS

11.1 Allergan
  11.1.1 Allergan Company Information
  11.1.2 Allergan Antispasmodics Drugs Product Offered
  11.1.3 Allergan Antispasmodics Drugs Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Allergan Main Business Overview
  11.1.5 Allergan Latest Developments
11.2 Hikma Pharmaceuticals
  11.2.1 Hikma Pharmaceuticals Company Information
  11.2.2 Hikma Pharmaceuticals Antispasmodics Drugs Product Offered
  11.2.3 Hikma Pharmaceuticals Antispasmodics Drugs Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Hikma Pharmaceuticals Main Business Overview
  11.2.5 Hikma Pharmaceuticals Latest Developments
11.3 Lannett
  11.3.1 Lannett Company Information
  11.3.2 Lannett Antispasmodics Drugs Product Offered
  11.3.3 Lannett Antispasmodics Drugs Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Lannett Main Business Overview
  11.3.5 Lannett Latest Developments
11.4 Mylan
  11.4.1 Mylan Company Information
  11.4.2 Mylan Antispasmodics Drugs Product Offered
  11.4.3 Mylan Antispasmodics Drugs Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Mylan Main Business Overview
  11.4.5 Mylan Latest Developments
11.5 Nexus Pharmaceuticals
  11.5.1 Nexus Pharmaceuticals Company Information
  11.5.2 Nexus Pharmaceuticals Antispasmodics Drugs Product Offered
  11.5.3 Nexus Pharmaceuticals Antispasmodics Drugs Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Nexus Pharmaceuticals Main Business Overview
  11.5.5 Nexus Pharmaceuticals Latest Developments
11.6 Akorn
  11.6.1 Akorn Company Information
  11.6.2 Akorn Antispasmodics Drugs Product Offered
  11.6.3 Akorn Antispasmodics Drugs Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Akorn Main Business Overview
  11.6.5 Akorn Latest Developments
11.7 Aurobindo Pharma
  11.7.1 Aurobindo Pharma Company Information
  11.7.2 Aurobindo Pharma Antispasmodics Drugs Product Offered
  11.7.3 Aurobindo Pharma Antispasmodics Drugs Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 Aurobindo Pharma Main Business Overview
  11.7.5 Aurobindo Pharma Latest Developments
11.8 Daiichi Sankyo
  11.8.1 Daiichi Sankyo Company Information
  11.8.2 Daiichi Sankyo Antispasmodics Drugs Product Offered
  11.8.3 Daiichi Sankyo Antispasmodics Drugs Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 Daiichi Sankyo Main Business Overview
  11.8.5 Daiichi Sankyo Latest Developments
11.9 Fresenius Kabi
  11.9.1 Fresenius Kabi Company Information
  11.9.2 Fresenius Kabi Antispasmodics Drugs Product Offered
  11.9.3 Fresenius Kabi Antispasmodics Drugs Revenue, Gross Margin and Market Share (2020-2025)
  11.9.4 Fresenius Kabi Main Business Overview
  11.9.5 Fresenius Kabi Latest Developments
11.10 Shanghai Fosun Pharmaceutical
  11.10.1 Shanghai Fosun Pharmaceutical Company Information
  11.10.2 Shanghai Fosun Pharmaceutical Antispasmodics Drugs Product Offered
  11.10.3 Shanghai Fosun Pharmaceutical Antispasmodics Drugs Revenue, Gross Margin and Market Share (2020-2025)
  11.10.4 Shanghai Fosun Pharmaceutical Main Business Overview
  11.10.5 Shanghai Fosun Pharmaceutical Latest Developments
11.11 SunGen Pharma
  11.11.1 SunGen Pharma Company Information
  11.11.2 SunGen Pharma Antispasmodics Drugs Product Offered
  11.11.3 SunGen Pharma Antispasmodics Drugs Revenue, Gross Margin and Market Share (2020-2025)
  11.11.4 SunGen Pharma Main Business Overview
  11.11.5 SunGen Pharma Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Antispasmodics Drugs Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Antispasmodics Drugs Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Oral
Table 4. Major Players of Injectable
Table 5. Major Players of Others
Table 6. Antispasmodics Drugs Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 7. Global Antispasmodics Drugs Market Size by Type (2020-2025) & ($ millions)
Table 8. Global Antispasmodics Drugs Market Size Market Share by Type (2020-2025)
Table 9. Antispasmodics Drugs Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 10. Global Antispasmodics Drugs Market Size by Application (2020-2025) & ($ millions)
Table 11. Global Antispasmodics Drugs Market Size Market Share by Application (2020-2025)
Table 12. Global Antispasmodics Drugs Revenue by Player (2020-2025) & ($ millions)
Table 13. Global Antispasmodics Drugs Revenue Market Share by Player (2020-2025)
Table 14. Antispasmodics Drugs Key Players Head office and Products Offered
Table 15. Antispasmodics Drugs Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Antispasmodics Drugs Market Size by Region (2020-2025) & ($ millions)
Table 19. Global Antispasmodics Drugs Market Size Market Share by Region (2020-2025)
Table 20. Global Antispasmodics Drugs Revenue by Country/Region (2020-2025) & ($ millions)
Table 21. Global Antispasmodics Drugs Revenue Market Share by Country/Region (2020-2025)
Table 22. Americas Antispasmodics Drugs Market Size by Country (2020-2025) & ($ millions)
Table 23. Americas Antispasmodics Drugs Market Size Market Share by Country (2020-2025)
Table 24. Americas Antispasmodics Drugs Market Size by Type (2020-2025) & ($ millions)
Table 25. Americas Antispasmodics Drugs Market Size Market Share by Type (2020-2025)
Table 26. Americas Antispasmodics Drugs Market Size by Application (2020-2025) & ($ millions)
Table 27. Americas Antispasmodics Drugs Market Size Market Share by Application (2020-2025)
Table 28. APAC Antispasmodics Drugs Market Size by Region (2020-2025) & ($ millions)
Table 29. APAC Antispasmodics Drugs Market Size Market Share by Region (2020-2025)
Table 30. APAC Antispasmodics Drugs Market Size by Type (2020-2025) & ($ millions)
Table 31. APAC Antispasmodics Drugs Market Size by Application (2020-2025) & ($ millions)
Table 32. Europe Antispasmodics Drugs Market Size by Country (2020-2025) & ($ millions)
Table 33. Europe Antispasmodics Drugs Market Size Market Share by Country (2020-2025)
Table 34. Europe Antispasmodics Drugs Market Size by Type (2020-2025) & ($ millions)
Table 35. Europe Antispasmodics Drugs Market Size by Application (2020-2025) & ($ millions)
Table 36. Middle East & Africa Antispasmodics Drugs Market Size by Region (2020-2025) & ($ millions)
Table 37. Middle East & Africa Antispasmodics Drugs Market Size by Type (2020-2025) & ($ millions)
Table 38. Middle East & Africa Antispasmodics Drugs Market Size by Application (2020-2025) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Antispasmodics Drugs
Table 40. Key Market Challenges & Risks of Antispasmodics Drugs
Table 41. Key Industry Trends of Antispasmodics Drugs
Table 42. Global Antispasmodics Drugs Market Size Forecast by Region (2026-2031) & ($ millions)
Table 43. Global Antispasmodics Drugs Market Size Market Share Forecast by Region (2026-2031)
Table 44. Global Antispasmodics Drugs Market Size Forecast by Type (2026-2031) & ($ millions)
Table 45. Global Antispasmodics Drugs Market Size Forecast by Application (2026-2031) & ($ millions)
Table 46. Allergan Details, Company Type, Antispasmodics Drugs Area Served and Its Competitors
Table 47. Allergan Antispasmodics Drugs Product Offered
Table 48. Allergan Antispasmodics Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 49. Allergan Main Business
Table 50. Allergan Latest Developments
Table 51. Hikma Pharmaceuticals Details, Company Type, Antispasmodics Drugs Area Served and Its Competitors
Table 52. Hikma Pharmaceuticals Antispasmodics Drugs Product Offered
Table 53. Hikma Pharmaceuticals Antispasmodics Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 54. Hikma Pharmaceuticals Main Business
Table 55. Hikma Pharmaceuticals Latest Developments
Table 56. Lannett Details, Company Type, Antispasmodics Drugs Area Served and Its Competitors
Table 57. Lannett Antispasmodics Drugs Product Offered
Table 58. Lannett Antispasmodics Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 59. Lannett Main Business
Table 60. Lannett Latest Developments
Table 61. Mylan Details, Company Type, Antispasmodics Drugs Area Served and Its Competitors
Table 62. Mylan Antispasmodics Drugs Product Offered
Table 63. Mylan Antispasmodics Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 64. Mylan Main Business
Table 65. Mylan Latest Developments
Table 66. Nexus Pharmaceuticals Details, Company Type, Antispasmodics Drugs Area Served and Its Competitors
Table 67. Nexus Pharmaceuticals Antispasmodics Drugs Product Offered
Table 68. Nexus Pharmaceuticals Antispasmodics Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 69. Nexus Pharmaceuticals Main Business
Table 70. Nexus Pharmaceuticals Latest Developments
Table 71. Akorn Details, Company Type, Antispasmodics Drugs Area Served and Its Competitors
Table 72. Akorn Antispasmodics Drugs Product Offered
Table 73. Akorn Antispasmodics Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 74. Akorn Main Business
Table 75. Akorn Latest Developments
Table 76. Aurobindo Pharma Details, Company Type, Antispasmodics Drugs Area Served and Its Competitors
Table 77. Aurobindo Pharma Antispasmodics Drugs Product Offered
Table 78. Aurobindo Pharma Antispasmodics Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 79. Aurobindo Pharma Main Business
Table 80. Aurobindo Pharma Latest Developments
Table 81. Daiichi Sankyo Details, Company Type, Antispasmodics Drugs Area Served and Its Competitors
Table 82. Daiichi Sankyo Antispasmodics Drugs Product Offered
Table 83. Daiichi Sankyo Antispasmodics Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 84. Daiichi Sankyo Main Business
Table 85. Daiichi Sankyo Latest Developments
Table 86. Fresenius Kabi Details, Company Type, Antispasmodics Drugs Area Served and Its Competitors
Table 87. Fresenius Kabi Antispasmodics Drugs Product Offered
Table 88. Fresenius Kabi Antispasmodics Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 89. Fresenius Kabi Main Business
Table 90. Fresenius Kabi Latest Developments
Table 91. Shanghai Fosun Pharmaceutical Details, Company Type, Antispasmodics Drugs Area Served and Its Competitors
Table 92. Shanghai Fosun Pharmaceutical Antispasmodics Drugs Product Offered
Table 93. Shanghai Fosun Pharmaceutical Antispasmodics Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 94. Shanghai Fosun Pharmaceutical Main Business
Table 95. Shanghai Fosun Pharmaceutical Latest Developments
Table 96. SunGen Pharma Details, Company Type, Antispasmodics Drugs Area Served and Its Competitors
Table 97. SunGen Pharma Antispasmodics Drugs Product Offered
Table 98. SunGen Pharma Antispasmodics Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 99. SunGen Pharma Main Business
Table 100. SunGen Pharma Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Antispasmodics Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Antispasmodics Drugs Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Antispasmodics Drugs Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Antispasmodics Drugs Sales Market Share by Country/Region (2024)
Figure 8. Antispasmodics Drugs Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Antispasmodics Drugs Market Size Market Share by Type in 2024
Figure 10. Antispasmodics Drugs in Hospital
Figure 11. Global Antispasmodics Drugs Market: Hospital (2020-2025) & ($ millions)
Figure 12. Antispasmodics Drugs in Special Clinic
Figure 13. Global Antispasmodics Drugs Market: Special Clinic (2020-2025) & ($ millions)
Figure 14. Antispasmodics Drugs in Home Care
Figure 15. Global Antispasmodics Drugs Market: Home Care (2020-2025) & ($ millions)
Figure 16. Antispasmodics Drugs in Others
Figure 17. Global Antispasmodics Drugs Market: Others (2020-2025) & ($ millions)
Figure 18. Global Antispasmodics Drugs Market Size Market Share by Application in 2024
Figure 19. Global Antispasmodics Drugs Revenue Market Share by Player in 2024
Figure 20. Global Antispasmodics Drugs Market Size Market Share by Region (2020-2025)
Figure 21. Americas Antispasmodics Drugs Market Size 2020-2025 ($ millions)
Figure 22. APAC Antispasmodics Drugs Market Size 2020-2025 ($ millions)
Figure 23. Europe Antispasmodics Drugs Market Size 2020-2025 ($ millions)
Figure 24. Middle East & Africa Antispasmodics Drugs Market Size 2020-2025 ($ millions)
Figure 25. Americas Antispasmodics Drugs Value Market Share by Country in 2024
Figure 26. United States Antispasmodics Drugs Market Size Growth 2020-2025 ($ millions)
Figure 27. Canada Antispasmodics Drugs Market Size Growth 2020-2025 ($ millions)
Figure 28. Mexico Antispasmodics Drugs Market Size Growth 2020-2025 ($ millions)
Figure 29. Brazil Antispasmodics Drugs Market Size Growth 2020-2025 ($ millions)
Figure 30. APAC Antispasmodics Drugs Market Size Market Share by Region in 2024
Figure 31. APAC Antispasmodics Drugs Market Size Market Share by Type (2020-2025)
Figure 32. APAC Antispasmodics Drugs Market Size Market Share by Application (2020-2025)
Figure 33. China Antispasmodics Drugs Market Size Growth 2020-2025 ($ millions)
Figure 34. Japan Antispasmodics Drugs Market Size Growth 2020-2025 ($ millions)
Figure 35. South Korea Antispasmodics Drugs Market Size Growth 2020-2025 ($ millions)
Figure 36. Southeast Asia Antispasmodics Drugs Market Size Growth 2020-2025 ($ millions)
Figure 37. India Antispasmodics Drugs Market Size Growth 2020-2025 ($ millions)
Figure 38. Australia Antispasmodics Drugs Market Size Growth 2020-2025 ($ millions)
Figure 39. Europe Antispasmodics Drugs Market Size Market Share by Country in 2024
Figure 40. Europe Antispasmodics Drugs Market Size Market Share by Type (2020-2025)
Figure 41. Europe Antispasmodics Drugs Market Size Market Share by Application (2020-2025)
Figure 42. Germany Antispasmodics Drugs Market Size Growth 2020-2025 ($ millions)
Figure 43. France Antispasmodics Drugs Market Size Growth 2020-2025 ($ millions)
Figure 44. UK Antispasmodics Drugs Market Size Growth 2020-2025 ($ millions)
Figure 45. Italy Antispasmodics Drugs Market Size Growth 2020-2025 ($ millions)
Figure 46. Russia Antispasmodics Drugs Market Size Growth 2020-2025 ($ millions)
Figure 47. Middle East & Africa Antispasmodics Drugs Market Size Market Share by Region (2020-2025)
Figure 48. Middle East & Africa Antispasmodics Drugs Market Size Market Share by Type (2020-2025)
Figure 49. Middle East & Africa Antispasmodics Drugs Market Size Market Share by Application (2020-2025)
Figure 50. Egypt Antispasmodics Drugs Market Size Growth 2020-2025 ($ millions)
Figure 51. South Africa Antispasmodics Drugs Market Size Growth 2020-2025 ($ millions)
Figure 52. Israel Antispasmodics Drugs Market Size Growth 2020-2025 ($ millions)
Figure 53. Turkey Antispasmodics Drugs Market Size Growth 2020-2025 ($ millions)
Figure 54. GCC Countries Antispasmodics Drugs Market Size Growth 2020-2025 ($ millions)
Figure 55. Americas Antispasmodics Drugs Market Size 2026-2031 ($ millions)
Figure 56. APAC Antispasmodics Drugs Market Size 2026-2031 ($ millions)
Figure 57. Europe Antispasmodics Drugs Market Size 2026-2031 ($ millions)
Figure 58. Middle East & Africa Antispasmodics Drugs Market Size 2026-2031 ($ millions)
Figure 59. United States Antispasmodics Drugs Market Size 2026-2031 ($ millions)
Figure 60. Canada Antispasmodics Drugs Market Size 2026-2031 ($ millions)
Figure 61. Mexico Antispasmodics Drugs Market Size 2026-2031 ($ millions)
Figure 62. Brazil Antispasmodics Drugs Market Size 2026-2031 ($ millions)
Figure 63. China Antispasmodics Drugs Market Size 2026-2031 ($ millions)
Figure 64. Japan Antispasmodics Drugs Market Size 2026-2031 ($ millions)
Figure 65. Korea Antispasmodics Drugs Market Size 2026-2031 ($ millions)
Figure 66. Southeast Asia Antispasmodics Drugs Market Size 2026-2031 ($ millions)
Figure 67. India Antispasmodics Drugs Market Size 2026-2031 ($ millions)
Figure 68. Australia Antispasmodics Drugs Market Size 2026-2031 ($ millions)
Figure 69. Germany Antispasmodics Drugs Market Size 2026-2031 ($ millions)
Figure 70. France Antispasmodics Drugs Market Size 2026-2031 ($ millions)
Figure 71. UK Antispasmodics Drugs Market Size 2026-2031 ($ millions)
Figure 72. Italy Antispasmodics Drugs Market Size 2026-2031 ($ millions)
Figure 73. Russia Antispasmodics Drugs Market Size 2026-2031 ($ millions)
Figure 74. Egypt Antispasmodics Drugs Market Size 2026-2031 ($ millions)
Figure 75. South Africa Antispasmodics Drugs Market Size 2026-2031 ($ millions)
Figure 76. Israel Antispasmodics Drugs Market Size 2026-2031 ($ millions)
Figure 77. Turkey Antispasmodics Drugs Market Size 2026-2031 ($ millions)
Figure 78. Global Antispasmodics Drugs Market Size Market Share Forecast by Type (2026-2031)
Figure 79. Global Antispasmodics Drugs Market Size Market Share Forecast by Application (2026-2031)
Figure 80. GCC Countries Antispasmodics Drugs Market Size 2026-2031 ($ millions)